Iranian Medicine Saving Lives of Americans while US Sanctions Killing Iranian Patients

Iranian medicine has been saving the lives of Americans while the illegal US-led sanctions against the Islamic Republic have been adversely affecting the lives of many Iranian patients.

A Sunday report on the website of the Wall Street Journal said the US Defense Department needs Iranian-researched and -produced medicine to treat the foreign forces in Afghanistan who get bitten by “Oxus cobras, Haly’s pit vipers” and other snakes peculiar to southwest Asia.

“Medical guidance issued by US Central Command says drugs made by Iran’s Razi Vaccine & Serum Research Institute ‘should be the first line of antivenin therapy,’” the report cited a US officer as saying.

“The Iranian antivenin is the best,” said Colonel Rob Russell, the medical director of the pharmacy at British-run Camp Bastion hospital, adjacent to the Camp Leatherneck US Marine base in southern Afghanistan.

The report highlighted the fact that antivenins produced in the US and approved by the US Food and Drug Administration (FDA) “won’t work on Afghan snake bites.”

This comes as the US-engineered sanctions are putting the lives of Iranian patients in jeopardy. Though the US has not imposed any bans on American firms to sell medicine and medical supplies to Iran, exporters have been required to apply for special licenses. In the wake of the sanctions, the impossibility of transferring money through banks has cast its cumbersome shadow upon medicine and healthcare in Iran, thereby jeopardizing the lives of millions of patients suffering from special diseases such as thalassemia, hemophilia, hepatitis, multiple sclerosis, diabetes, and many others.

In November, a hemophiliac Iranian teenager lost his life in hospital due to the shortage of required medication caused by the US-led sanctions against the Islamic Republic.

“The sheer idea of imposing illegal sanctions against the Islamic Republic and jeopardizing the lives of millions of patients is indeed an act of brutality which runs counter to the very true spirit of humanity as well as to international humanitarian laws,” Dr. Salami wrote in an op-ed on the website of Press TV on October 19.

Referring to the Iranian antidotes, Hadi Zareh, the lead researcher in Razi’s antivenin department, said, “We make this to save lives, and it doesn’t matter if the person is Iranian or Afghan or American. We are happy to hear we have saved a person’s life, even an American soldier.”

The illegal US-engineered sanctions were imposed based on the unfounded accusation that Iran is pursuing non-civilian objectives in its nuclear energy program.

Iran rejects the allegations, arguing that as a committed signatory to the nuclear Non-Proliferation Treaty (NPT) and a member of the International Atomic Energy Agency (IAEA), it has the right to use nuclear technology for peaceful purposes.


Articles by: Press TV

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]